181 related articles for article (PubMed ID: 15880642)
1. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
2. Strategies for targeting protein-protein interactions with synthetic agents.
Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions as targets for antiviral chemotherapy.
Loregian A; Marsden HS; Palù G
Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein-protein interactions using designed molecules.
Wilson AJ
Chem Soc Rev; 2009 Dec; 38(12):3289-300. PubMed ID: 20449049
[TBL] [Abstract][Full Text] [Related]
5. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
6. Emerging classes of protein-protein interaction inhibitors and new tools for their development.
Pagliaro L; Felding J; Audouze K; Nielsen SJ; Terry RB; Krog-Jensen C; Butcher S
Curr Opin Chem Biol; 2004 Aug; 8(4):442-9. PubMed ID: 15288255
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions as targets for small molecule drug discovery.
Fry DC
Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting protein-protein interactions using designed molecules.
Zhao L; Chmielewski J
Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
[TBL] [Abstract][Full Text] [Related]
9. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
10. Autoinhibited proteins as promising drug targets.
Peterson JR; Golemis EA
J Cell Biochem; 2004 Sep; 93(1):68-73. PubMed ID: 15352163
[TBL] [Abstract][Full Text] [Related]
11. Modulation of protein-protein interactions with small organic molecules.
Berg T
Angew Chem Int Ed Engl; 2003 Jun; 42(22):2462-81. PubMed ID: 12800163
[TBL] [Abstract][Full Text] [Related]
12. Developing therapeutic proteins by engineering ligand-receptor interactions.
Jones DS; Silverman AP; Cochran JR
Trends Biotechnol; 2008 Sep; 26(9):498-505. PubMed ID: 18675482
[TBL] [Abstract][Full Text] [Related]
13. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
Buchwald P
IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
[TBL] [Abstract][Full Text] [Related]
15. Modulation of biomolecular interactions with complex-binding small molecules.
Cai Z; Greene MI; Berezov A
Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
18. A large-scale computational approach to drug repositioning.
Li YY; An J; Jones SJ
Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
[TBL] [Abstract][Full Text] [Related]
19. Rational drug design via intrinsically disordered protein.
Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
[TBL] [Abstract][Full Text] [Related]
20. Drugs targeting protein-protein interactions.
Chène P
ChemMedChem; 2006 Apr; 1(4):400-11. PubMed ID: 16892375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
